By Martin Bricketto ( October 19, 2011, 1:46 PM EDT) -- Abbott Laboratories will split into two publicly traded companies that will respectively focus on research-based pharmaceuticals and diversified medical products, including generic drugs, to boost growth and stock returns, the company announced Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.